Insights

Helping Healthcare clients raise funds

Panmure Gordon has executed two fundraisings for
long-standing clients: a £10 million placing for MaxCyte and a £12 million
placing for Midatech.

Panmure Gordon acted as sole advisor to MaxCyte for its
fundraising, which it will use to develop new cancer therapy and to invest in
its core business.

The firm was Nomad and Joint Broker for Midatech on its
placing, which it will use to develop new oncology and rare disease therapies.

Freddy Crossley, Head of Healthcare, said: “We have worked closely with Midatech and MaxCyte for a number of years as they’ve invested and developed novel new therapies. We are delighted to continue to support their growth through their latest fundraisings.”